Bloomage Accounts Payable from 2010 to 2025

688363 Stock   50.20  0.36  0.71%   
Bloomage Biotechnology Co's Accounts Payable is increasing over the years with slightly volatile fluctuation. Overall, Accounts Payable is expected to go to about 846.2 M this year. Accounts Payable is the amount Bloomage Biotechnology Corp owes to suppliers or vendors for products or services received but not yet paid for. It represents Bloomage Biotechnology Co's short-term liabilities. View All Fundamentals
 
Accounts Payable  
First Reported
2019-03-31
Previous Quarter
656.4 M
Current Value
787.4 M
Quarterly Volatility
277.7 M
 
Covid
Check Bloomage Biotechnology Co financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bloomage Biotechnology Co's main balance sheet or income statement drivers, such as Interest Expense of 13 M, Other Operating Expenses of 6.3 B or Net Income Applicable To Common Shares of 562.4 M, as well as many indicators such as . Bloomage financial statements analysis is a perfect complement when working with Bloomage Biotechnology Co Valuation or Volatility modules.
  
This module can also supplement various Bloomage Biotechnology Co Technical models . Check out the analysis of Bloomage Biotechnology Co Correlation against competitors.

Currently Active Assets on Macroaxis

Other Information on Investing in Bloomage Stock

Bloomage Biotechnology Co financial ratios help investors to determine whether Bloomage Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bloomage with respect to the benefits of owning Bloomage Biotechnology Co security.